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Background. There are several health beneﬁts that honeybee products such as honey, propolis, and royal jelly claim toward various
types of diseases in addition to being food. Scope and Approach. In this paper, the eﬀects of honey, propolis, and royal jelly on
diﬀerent metabolic diseases, cancers, and other diseases have been reviewed. The modes of actions of these products have also
been illustrated for purposes of better understanding. Key Findings and Conclusions. An overview of honey, propolis, and royal
jelly and their biological potentials was highlighted. The potential health beneﬁts of honey, such as microbial inhibition, wound
healing, and its eﬀects on other diseases, are described. Propolis has been reported to have various health beneﬁts related to
gastrointestinal disorders, allergies, and gynecological, oral, and dermatological problems. Royal jelly is well known for its
protective eﬀects on reproductive health, neurodegenerative disorders, wound healing, and aging. Nevertheless, the exact
mechanisms of action of honey, propolis, and royal jelly on the abovementioned diseases and activities have not been not fully
elucidated, and further research is warranted to explain their exact contributions.
1. Introduction
Apiculture is the science and art of prolonging, sustaining,
and retaining health by using products obtained from honey-
bee hives, such as honey, bee bread, bee venom, bee pollen,
propolis, and royal jelly. Recent years have seen the fast
application of bee products in both traditional and modern
medicine. Currently, many studies are targeted toward
investigating directed health beneﬁts and pharmacological
properties of bee products due to their eﬃcacies, leading
to the increasing development of nutraceuticals and func-
tional food from these products. The concept of functional
food refers to food that has the ability to promote better
physiological or psychological health compared to traditional
remediated and nutritional food. These eﬀects positively con-
tribute toward excellent health maintenance, well-being, and
reduced chronic illness [1]. The present review focuses on the
potential health beneﬁts of bee products, including honey,
propolis, and royal jelly.
Honey is a sweet liquid processed by the honey bee.
Honey is recognized worldwide due to its high nutritive
components that are beneﬁcial for human well-being. It has
been traditionally used by Egyptians, Greeks, Romans, and
Chinese to heal wounds and diseases of the gut, including
gastric ulcers. It has also been used as a remedy for cough,
sore throat, and earaches [2]. In India, Lotus honey has been
traditionally used to treat eye infections and other diseases.
In addition to being used externally, honey is also used inter-
nally [3] as a functional food to provide energy and nourish-
ment to enhance vital organs in the body [4]. This has been in
practice since ancient times. The active components of
honey, such as glucose, fructose, ﬂavonoid, polyphenols,
and organic acids, play an important role in its quality [5].
Honey is being produced in many countries all over the
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world and is recognized as an important medicine as well as
energy-providing food due to its functional properties and
nutritional values. Additionally, honey is well known for its
biological, physiological, and pharmacological activities.
Propolis is generally known as the “bee glue”, which is a
generic name that refers to the resinous substance accumu-
lated by the bees from diﬀerent types of plants. The word
“propolis” is derived from Greek to mean defense for “pro”
and city or community for “polis”, or the beehive, in other
words [6]. Propolis functions in sealing holes and cracks
and for the reconstruction of the beehive. It is also used for
smoothing the inner surface of the beehive, retaining the
hive’s internal temperature (35°C), preventing weathering
and invasion by predators. Furthermore, propolis hardens
the cell wall and contributes to an aseptic internal environ-
ment. Propolis generally becomes soft and sticky upon heat-
ing [7]. It also possesses a pleasant smell. Propolis and its
extracts have numerous applications in treating various
diseases due to its antiseptic, anti-inﬂammatory, antioxidant,
antibacterial, antimycotic, antifungal, antiulcer, anticancer,
and immunomodulatory properties.
Royal jelly, a white and viscous jelly-like substance, is a
form of hypopharyngeal and mandibular gland secretion
from the worker bees. It is also known as a “superfood” that
is solely consumed by the queen bee. Royal jelly is also fed to
the honeybee larvae upon hatching and helps to nurture the
brood [8]. It is the exclusive nutriment oﬀered to the imma-
ture young larvae in their ﬁrst 2-3 days of maturation besides
being used as a food speciﬁcally for the queen bee throughout
her entire life cycle. Royalactin is the main compound in
royal jelly that allows the morphological change of a larva
into the queen bee [9]. This superfood is the main reason
for the longevity of the queen bee compared to the other bees.
Royal jelly is widely used as a dietary nutritional complex to
help combat various chronic health conditions. Furthermore,
it is one of the proﬁtable remedies for human beings in both
traditional and modern medicine. Many pharmacological
activities such as antibacterial, antitumor, antiallergy, anti-
inﬂammatory, and immunomodulatory eﬀects have also
been attributed to it.
2. Chemical Composition of Honey,
Propolis, and Royal Jelly
Honey is also known as a supersaturated sugar solution.
Natural honey is composed of 82.4% carbohydrates,
38.5% fructose, 31% glucose, 12.9% other sugars, 17.1%
water, 0.5% protein, organic acids, multiminerals, amino
acids, vitamins, phenols, and a myriad of other minor com-
pounds. In addition, honey consists of minor amounts of bio-
active components, including phenolic acid, ﬂavonoid, and
α-tocopherol [10]. Honey constituents with health beneﬁts
include phenolic acids, ﬂavonoids, ascorbic acid, proteins,
carotenoids, and certain enzymes, such as glucose oxidase
and catalase [11].
Propolis is the third most important component of bee
products. It is composed mainly of resin (50%), wax (30%),
essential oils (10%), pollen (5%), and other organic com-
pounds (5%) [12]. Phenolic compounds, esters, ﬂavonoids,
terpenes, beta-steroids, aromatic aldehydes, and alcohols
are the important organic compounds present in propolis
[13]. Twelve diﬀerent ﬂavonoids, namely, pinocembrin,
acacetin, chrysin, rutin, luteolin, kaempferol, apigenin, myr-
icetin, catechin, naringenin, galangin, and quercetin; two
phenolic acids, caﬀeic acid and cinnamic acid; and one stil-
bene derivative called resveratrol have been detected in prop-
olis extracts by capillary zone electrophoresis [14]. Propolis
also contains important vitamins, such as vitamins B1, B2,
B6, C, and E and useful minerals such as magnesium (Mg),
calcium (Ca), potassium (K), sodium (Na), copper (Cu), zinc
(Zn), manganese (Mn), and iron (Fe). A few enzymes, such as
succinic dehydrogenase, glucose-6-phosphatase, adenosine
triphosphatase, and acid phosphatase, are also present in
propolis [15].
Royal jelly consists of water (50%–60%), proteins (18%),
carbohydrates (15%), lipids (3%–6%), mineral salts (1.5%),
and vitamins [16]. Based on modern spectrometric analysis,
approximately 185 organic compounds have been detected
in royal jelly. Royalactin is the most important protein
present in royal jelly. In addition, royal jelly is composed
of a signiﬁcant number of bioactive compounds, including
10-hydroxy-2-decenoic acid (HAD), which has some
immunomodulatory properties [17]. Fatty acid, proteins,
adenosine monophosphate (AMP) N1 oxide, adenosine, ace-
tylcholine, polyphenols, and hormones such as testosterone,
progesterone, prolactin, and estradiol are other useful bioac-
tive components reported to be present in royal jelly [18].
3. Bioactive Compounds in Honey,
Propolis, and Royal Jelly
Honey, propolis, and royal jelly are highly rich in bioactive
compounds (Table 1). Essential and nonessential com-
pounds, such as polyphenols and vitamins occurring natu-
rally as part of food chains, are considered bioactive. These
compounds are naturally present in food and confer useful
health beneﬁts. Phenolic compounds are bioactive com-
pounds. Phenols are deﬁned as organic compounds with an
aromatic ring that is chemically bonded to one or additional
hydrogenated substituents in the presence of corresponding
functional derivatives [19].
In honey, propolis, and royal jelly, phenolic compounds
are commonly present as ﬂavonoids [20]. Various phenolic
compounds contribute to the functional properties of bee
products, including their antioxidant, antimicrobial, antivi-
ral, anti-inﬂammatory, antifungal, wound healing, and cardi-
oprotective activities [21]. Figure 1 summarizes the important
biological eﬃcacies of bee products.
4. Health Benefits of Honey
4.1. Wound Management. Honey has traditionally been used
to treat wounds, insect bites, burns, skin disorders, sores, and
boils. Scientiﬁc documentation of the wound-healing capa-
bilities of honey validates its eﬃcacy as a promoter of wound
repair and an antimicrobial agent [37]. Honey promotes the
activation of dormant plasminogen in the wound matrix,
which results in the dynamic expression of the proteolytic
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enzyme. Plasmin causes blood clot retraction and ﬁbrin
destructions. It is an enzyme that breaks down ﬁbrin clots
with attached dead tissues in the wound bed [38].
Clinical evidence supporting the eﬀectiveness, speciﬁcity,
and sensitivity of honey in wound care indicates that the
performance of conventional and modern wound care dress-
ing is inferior to that using honey [39]. Certain cases have
shown that honey stimulates wound-healing properties even
in infected wounds that do not respond to antiseptics or
antibiotics and wounds that have been infected with
antibiotic-resistant bacteria, such as methicillin-resistant
Staphylococcus aureus (MRSA) (Natarajan et al. 2001).
Honey also aids autolytic debridement and accelerates the
growth of healthy granulated wound bed [40].
Malodor is a general attribute of severe wounds caused by
anaerobic bacterial species belonging to Bacteroides spp. and
Peptostreptococcus spp. [41]. Malodourous compounds, such
as ammonia, amines, and sulfur, are produced by bacteria
during the metabolism of amino acids from putreﬁed serum
and tissue proteins. These compounds are replaced by lactic
acids as honey dispenses a substantial amount of glucose, a
substrate metabolized by bacteria in preference to amino
acids [42]. The therapeutic eﬀects observed after honey appli-
cation include fast healing, wound cleansing, clearance of
infection, tissue regeneration, minimized inﬂammation, and
increased comfort during dressing due to lower extent of
tissue adhesion [43].
4.2. Pediatric Care. Honey also controls skin damage near
stomas, such as ileostomy and colostomy, by enhancing epi-
thelialization of the aﬄicted skin surface [44]. Honey has a
beneﬁcial eﬀect on pediatric dermatitis caused by excessive
use of napkins and diapers, eczema, and psoriasis. The eﬀect
of honey mixed with beeswax and olive oil was investigated
on patients with psoriasis or atopic dermatitis condition. A
clinical trial showed that a mixture containing honey was
extremely well tolerated and caused signiﬁcant improve-
ments. Honey consists of various nitric oxide metabolites,
which reduce the incidence of skin infection in psoriasis [45].
4.3. Diabetic Foot Ulcer (DFU). Consumption of honey is a
low-cost and eﬀective therapy for the treatment of DFU.
DFU is often complicated by microbial infections and slows
the healing process. Apart from the infection, symptoms
such as pain, swelling, and redness might not be present for
diabetic peripheral neuropathy patients due to their reduced
immune response, which further complicates the diagnosis
[46]. A review indicated that using honey for the treatment
of venous ulcers yielded positive outcomes with good accep-
tance rates from the patients [47]. Honey is used in wound
management and is eﬀective among patients with locally
infected wounds, DFU, Charcot foot ulcerations, and com-
plex comorbid conditions that have failed hospital manage-
ment [48]. In addition, there is excellent tolerability and
minimal trauma to the wound bed in the presence of honey.
4.4. Gastrointestinal (GI) Disorder. Natural honey is com-
posed of enzymes that facilitate the absorption of molecules,
such as sugars and starch. The sugar molecules in honey are
in a form that can be easily absorbed by the body. Honey also
provides some nutrients, such as minerals, phytochemicals,
and ﬂavonoids, that aid digestive processes in the body
[49]. Pure honey has bactericidal properties against patho-
genic bacteria and enteropathogens, including Salmonella
spp., Escherichia coli, Shigella spp., and many other Gram-
negative species [50].
Biological activities of honey
Gastroprotective
Anti-
inflammatory
Wound healing
Cardioprotective
Antioxidant
Antidiabetic
Antibacterial
Anticancer
Figure 1: Various types of biological activities of honey products.
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The gastrointestinal tract (GIT) contains many impor-
tant beneﬁcial microbes. For example, Biﬁdobacteria is one
of the microorganisms present primarily for the suste-
nance of a healthy GI system. It has been suggested that
consuming foods rich in probiotics can increase the popu-
lation of Biﬁdobacteria in the GIT. The biological activities
and development of this bacteria are further enhanced in
the presence of prebiotics. Studies have shown that natural
honey contains high amount of prebiotics [51]. Some
in vitro and in vivo experimental trials on honey have
reported it as a prominent dietary supplement that hastens
the growth of Lactobacillus and Biﬁdobacteria and catalyzes
their probiotic potency in the GIT [52, 53]. Under in vitro
conditions, prebiotic ingredients in honey such as inulin,
oligofructose, and oligosaccharides promoted the increase
in the numbers of Lactobacillus acidophilus and L. plantarum
by 10–100 folds, which was beneﬁcial for the intestinal
microbiota [54].
4.5. Oral Health. Honey is useful for the treatment of many
oral diseases, including periodontal disease, stomatitis, and
halitosis. In addition, it has also been applied for the preven-
tion of dental plaque, gingivitis, mouth ulcers, and periodon-
titis. The antibacterial and anti-inﬂammatory properties of
honey can stimulate the growth of granulation tissue, leading
to the repair of damaged cells [55]. Porphyromonas gingivalis
is a Gram-negative bacteria that causes periodontitis.
Honey exerts antimicrobial activity against this anaerobic
bacteria and prevents periodontal disease [56]. Inﬂamma-
tion of mucous membranes in the mouth (stomatitis)
may induce redness and swelling of oral tissues and cause
distinct and painful ulcers. Honey penetrates into the tissues
very quickly and is eﬀective against stomatitis [57, 58].
Halitosis is an oral health condition that causes malodor-
ous breath. Most of the odor in the oral cavity is caused
by the activity of degrading microbes [59]. A recent study
has reported that honey consumption ameliorates halitosis
due to its strong antibacterial activity resulting from its
methylglyoxal component [60].
4.6. Pharyngitis and Coughs. Pharyngitis, commonly known
as sore throat, is an acute infection induced by Streptococcus
spp. in the oropharynx and nasopharynx [61]. In addition to
streptococci, viruses, nonstreptococcal bacteria, fungi, and
irritants such as chemical pollutants may also cause sore
throat. Manuka honey is eﬀective for treating sore throat
with its anti-inﬂammatory, antiviral, and antifungal proper-
ties. Honey coats the inner lining of the throat and destroys
the harmful microbes while simultaneously soothing the
throat [62, 63].
A survey has demonstrated that honey is superior to
other treatments for cough induced by upper respiratory
infections, including dextromethorphan and diphenhydra-
mine [64]. The antioxidant and antimicrobial properties of
honey aided in minimizing persistent cough and ameliorated
sleep for both children and adults following honey intake
(2.5ml). A comparative study on children with diﬀerent
natural products reported that honey was found to be the
widely used remedy for pneumonia 82.4% [65].
4.7. Gastroesophageal Reﬂux Disease. Gastroesophageal
reﬂux disease (GERD) is a mucosal infection caused by con-
tents of abnormal gastric reﬂux into the esophagus and even
the lungs. Symptoms of GERD include heartburn, inﬂamma-
tion, and acid regurgitation. Consumption of honey helps
this condition by coating the esophagus and stomach lining,
thus preventing the upward ﬂow of food and gastric juice.
Honey can further stimulate the tissues on the sphincter to
assist in their regrowth and ﬁnally reduce the chances of acid
reﬂux [66].
4.8. Dyspepsia, Gastritis, and Peptic Ulcer. Dyspepsia is a
chronic disease in which the GI organs, mainly the stomach
and ﬁrst part of the small intestine, function abnormally. It
is a disease that causes epigastric pain, heartburn, bloating,
and nausea as symptoms. Dyspepsia is the preliminary symp-
tom of peptic ulcer which could eventually cause cancer. Gas-
tritis refers to the irritation and inﬂammation of the lining of
the stomach wall. Peptic ulcer denotes erosions or open pain-
ful ulcers on the lining of the stomach or duodenum. Honey
have been identiﬁed as a potent inhibitor for gastritis and the
peptic ulcer causing agent, Helicobacter pylori (H. pylori)
[67]. Clinical surveys have shown that honey decreased the
secretion of gastric acid and increased the healing eﬀect.
Thus, honey is taken as a dietary supplement for its antibac-
terial properties and protective eﬀect [68]. The high sugar
content and low pH in honey are the results of glucose oxida-
tive conversion to gluconic acid by glucose oxidase. This
mechanism releases hydrogen peroxide, which functions as
an antibacterial agent. Glucose oxidase also acts on ﬁbro-
blasts and epithelial cell activators required for the healing
of ulcers caused by H. pylori [51].
4.9. Gastroenteritis. Gastroenteritis, known as stomach or
gastric ﬂu, causes inﬂammation of the digestive tract. This
condition may be due to foodborne, waterborne, and
person-to-person spread of infectious agents. The symptoms
of gastroenteritis include dehydration, watery diarrhea,
bloating, abdominal cramps, and nausea. There are many
infectious agents, such as Salmonella, Shigella, and Clostrid-
ium, that can cause this condition [69]. A clinical study by
Abdulrahman, 2010, has reported the treatment of infantile
gastroenteritis using honey. The study found that replacing
the glucose in standard electrolyte oral rehydration solution
(ORS) with honey reduced the recovery time of patients with
gastroenteritis because the high sugar content in honey
boosts electrolyte and water reabsorption in the gut [70].
4.10. Constipation and Diarrhea. Chronic constipation is a
common andmultifarious illness characterized by intolerable
defecation (irregular stools and diﬃcult stool passage).
Diﬃcult stool passage includes symptoms such as straining,
hard to expel stool, a sense of incomplete evacuation, hard
or lumpy stools, and prolonged time to pass stool [71].
Diarrhea is deﬁned as a high frequency of bowel movements
with watery stool. Honey has minimized the pathogenesis
and duration of viral diarrhea compared to conventional
antiviral therapy [72]. In another case, people diagnosed with
inﬂammatory bowel syndrome (IBS) experiencing severe
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diarrhea or constipation, bloating, and stomach discomfort
was successfully treated with raw Manuka honey on an
empty stomach [73].
4.11. Liver and Pancreatic Diseases. Honey helps to soothe
pain, balance liver systems, and neutralize toxins. Complica-
tions in the liver system can be attributed to oxidative dam-
age. Honey exhibits antioxidant activities that have a
potential protective eﬀect on the damaged liver. A study on
paracetamol-induced liver damage rats showed that the anti-
oxidant and hepatoprotective activity of honey minimized
liver damage [74]. Honey, which has a 1 : 1 ratio of fructose
to glucose, may help to promote better blood sugar level,
which is useful for those suﬀering from fatty liver disease
since it provides adequate glycogen storage in liver cells.
Insuﬃcient glycogen storage in the liver releases stress hor-
mones that impair glucose metabolism over time. Impaired
glucose metabolism leads to insulin resistance and is the
main factor of fatty liver disease. Another study reported sig-
niﬁcant reduction in blood glucose levels after treatment with
Tualang honey [75, 76].
4.12. Metabolic and Cardiovascular Health. Natural wild
honey exerts cardioprotective and therapeutic impacts
against epinephrine-induced cardiac disorders and vasomo-
tor dysfunctions. A harmonized relationship between radical
scavenging activity and the total phenolic content of honey
has been observed [77]. Honey intake showed a signiﬁcant
reduction in risk factors of metabolic and cardiovascular dis-
eases. Honey exhibits cardioprotective eﬀects such as vasodi-
lation, balancing vascular homeostasis, and improvements in
lipid proﬁle [78]. Flavonoids in honey improves coronary
vasodilation, decreases the ability of platelets to form clots,
prevents oxidation of low-density lipoproteins (LDL),
increases high-density lipoproteins (HDL), and improves
endothelial functions [79].
A study conducted to compare the metabolic response of
honey has indicated its ameliorative eﬀects against metabolic
syndromes (MetS) [80]. MetS is denoted by hyperglycemia,
hypertension, abdominal obesity, dyslipidemia, and inten-
siﬁed adaptability towards diabetes, kidney, and heart dis-
eases. Polyphenols in honey reduce atherosclerotic lesions
through the downregulation of inﬂammatory and angiogenic
mechanisms [81]. A clinical study conducted on patients
with hyperlipidemia showed that honey decreased total
cholesterol (TC) and noticeably prevented the rise in plasma
glucose levels. Nitric oxide (NO) is a metabolite present in
honey that also has cardioprotective functions [82].
4.13. Cancer and Oncogenesis
4.13.1. Breast Cancer. Imbalance in estrogen signaling path-
ways and propagating levels of estrogens have important
roles in breast cancer growth and propagation [83]. Treat-
ments for breast cancer are associated with targeting the
estrogen receptor (ER) signaling pathway. Phytoestrogens
are a subclass of phytochemicals with a common structure
to the mammalian estrogen that enables them to bind to
estrogen receptors. Several experimental studies have investi-
gated the eﬃciency of honey in modulating the ER signaling
pathway [84]. Another study has shown that honey has
biphasic activity in MCF-7 cells. This biphasic activity of
honey is represented by an antiestrogenic eﬀect at lower con-
centrations and an estrogenic eﬀect at higher concentrations,
which is caused when phytoestrogens bind to estrogen recep-
tors [85]. Moreover, quercetin has been reported to induce
apoptotic eﬀects through ER α- and ER β-dependent mecha-
nisms. On the other hand, cytotoxic activities of Tualang
honey in human breast cancer cells were demonstrated by
elevated secretion of lactate dehydrogenase (LDH) and fur-
ther illustrated the cytotoxic properties of honey. The study
also showed that honey only exerts cytotoxic eﬀects on breast
cancer line and not on nonmalignant breast cells. Therefore,
this indicates that Tualang honey shows highly speciﬁc and
selective cytotoxic eﬀects towards breast cancer cell lines
and has a good potential as a chemotherapeutic agent [86].
4.13.2. Liver Cancer. The most common type of liver cancer is
hepatocellular carcinoma (HCC). The antitumor eﬀects of
honey on liver cancer cells have been investigated in various
experimental studies. Treatment of HepG2 cells with honey
minimized the amount of nitric oxide (NO) levels in the cells
and decreased the HepG2 cell number greatly. This increased
the overall antioxidant proﬁle of the cells. The survival of
HepG2 cells is promoted by reactive oxygen species (ROS),
and adequate levels of ROS trigger cell proliferation and dif-
ferentiation. Decreasing the amount of NO resulting from
honey treatment supported this study. Thus, reduced ROS
and enhanced antioxidant eﬃcacy inhibit cancerous cell pro-
liferation and lowered the number of HepG2 cells [84].
Another study done by Abdel Aziz et al. investigated the
eﬀects of honey on HepG2 cell lines. The report showed that
honey exerted cytotoxic, antimetastatic, and antiangiogenic
eﬀects on HepG2 cells based on diﬀerent concentrations [87].
4.13.3. Colorectal Cancer. Most colorectal cancers begin as a
polyp, which generally starts on the inner lining of the colon
or rectum and grows towards the center. Some polyps are not
dangerous but some will eventually grow into adenomas and
can eventually result in cancer. A study [88] that investigated
the chemopreventive eﬀects of Gelam and Nenas monoﬂoral
honeys against colon cancer cell lines found that the honey
inhibited proliferation of colon cancer cells. Hydrogen
peroxide-induced inﬂammation in the colon cancer cells
was used to examine the eﬀect of honey. The results showed
that honey curbed inﬂammation in the cancerous cells [88].
Another study was done to investigate the apoptotic eﬀects
of crude honey on colon cancer cell lines. The study con-
ﬁrmed the antiproliferative eﬀect of honey in these cells. In
addition, at high phenolic concentrations (such as those of
quercetin and ﬂavonoids), signiﬁcant antiproliferative action
against colon cancer cells was observed [89].
The molecular mechanisms resulting in the antiprolifera-
tive and anticancer eﬀects of honey include cell cycle arrest,
activation of mitochondrial pathway, induction of mito-
chondrial outer membrane permeabilization, induction of
apoptosis, modulation of oxidative stress, reduction of
inﬂammation, modulation of insulin signaling, and inhibi-
tion of angiogenesis in cancer cells (Figure 2). In addition,
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honey shows potential eﬀects on cancer cell by modulating
proteins, genes, and cytokines that promote cancer.
Several components of honey such as chrysin, quercetin,
and kaempferol have been shown to arrest cell cycle at vari-
ous phases such as G0/G1, G1, and G2/M in human mela-
noma, renal, cervical, hepatoma, colon, and esophageal
adenocarcinoma cell lines. The mitochondrial pathway
entails a chain of interactions between stimuli such as nutri-
ents, physical stress, oxidative stress, and damage during
major cancer treatments including chemotherapy and radio-
therapy. These stimuli cause several proteins located within
the intermembrane space (IMS) of the mitochondria, such
as cytochrome c, to be released, which eventually culminates
in the death of the cell. Flavonoids in honey are eﬀective in
activating the mitochondrial pathway and discharging pro-
teins with potential cytotoxicity. Induction of mitochon-
drial outer membrane permeabilization (MOMP) is the
most prevalent anticancer mechanism, which causes the
leakage of proteins from the IMS and inevitably results in cell
death. Honey induces MOMP in cancer cell lines by decreas-
ing the mitochondrial membrane potential. Honey has also
been documented for amplifying the apoptotic eﬀect of
tamoxifen by intensiﬁed depolarization of the mitochondrial
membrane. Flavonoid constituents of honey, such as querce-
tin, have been shown to trigger MOMP and lead to cancer
cell death [84].
Apoptosis is a programmed cell death functioning to
control cell growth and remove damaged cells from the
system. This process also involves MOMP and results in
the discharge of IMS proapoptotic proteins such as cyto-
chrome c to activate caspase cascades which results in further
disruption of mitochondria and ﬁnally results in cancer cell
death. Inﬂuence of honey on enzymes, genes, and transcrip-
tion factors corresponding to apoptosis has been investi-
gated. Poly (ADP-ribose) polymerases (PARP) are crucial
enzymes involved in apoptosis and DNA repair. Inhibition
of PARP activity renders the cells unable to repair damaged
DNA and pass through the G2 and M phases of the cell
cycle. Thus, cell cycle is arrested. Because DNA repair is
impaired due to nonfunctioning PARP, the cells are being
classiﬁed as damaged, and consequently, apoptosis activity
may be augmented.
Inhibition of PARP activity by ﬂavonoids in honey is a
potential strategy for targeting cancers with defective DNA-
damage repair. Bcl-2 and Bax are antiapoptotic and proapop-
totic proteins, respectively. Bcl-2 is generally overexpressed
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Figure 2: Molecular mechanisms responsible for anticancer and antitumor activities of honey products. IRS—insulin receptor substrate,
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in cancer. Tumor suppressor p53 is a transcription factor
commonly inactivated in various types of tumors. It modu-
lates transcription of genes involved in apoptosis [84, 90].
Honey enhances the upregulation of Bax and downregula-
tion of Bcl-2. In addition, it activates caspases 3 and 9 and
induces p53, thereby inhibiting cancer.
Low levels of ROS intensify cell proliferation while high
levels lead to oxidative damage that contributes to various
types of cancer. Regulation of redox homeostasis is vital for
normal cell growth and proliferation. In this regard, honey
is an inﬂuential antioxidant and free radical scavenger. The
inhibitory eﬀect of honey on cancer growth and proliferation
is due to its ability to modulate oxidative stress. Honey
exhibits anticancer properties via antioxidant or pro-
oxidant mechanisms that are selectively dependent on the
state of oxidative stress in the cancer cells. If cancer growth
is rapid under high levels of ROS, honey acts as an antioxi-
dant to prevent cancer cell growth by minimizing oxidative
stress and scavenging the ROS. On the other hand, under
low levels of ROS, it may also act as a pro-oxidant and pro-
motes cancer cell growth by further generation of ROS and
maximizing oxidative stress. Thus, the eﬀects of honey on
cancer cell death are diﬀerent under diﬀerent conditions [84].
Inﬂammation is a contributing factor for the dysregula-
tion of physiological processes, which leads to various malig-
nancies and cancers. Mitogen-activated protein kinase
(MAPK) and nuclear factor kappa B (NF-κB) are the two
main pathways responsible for inﬂammatory response in
cells. Activation of MAPK and NF-κB activates proinﬂam-
matory genes and generates inﬂammatory proteins or
cytokines. These include cyclooxygenase-2 (COX-2), C-
reactive protein (CRP), lipoxygenase-2 (LOX-2), interleukins
(IL-1β, IL-6), and TNF-α. These components play crucial
roles in both angiogenesis and inﬂammatory responses cor-
responding to cancer. IL-1β, IL-6, and TNF-α are cytokines
that trigger cancer cell proliferation by maintaining the
inﬂammatory phenotype in the tumor microenvironment.
On the other hand, cyclooxygenase-2 (COX-2) and inducible
nitric oxide synthase (iNOS) yield essential endogenous
factors responsible for the tumor progression. The actions
of iNOS can be either inductive or inhibitory depending
on the tumor types.
Biological responses which facilitate inﬂammation can
promote tumorigenesis as severe inﬂammation is the major
factor for the development of cancer cells. Treating and
soothing of inﬂammation aid to suppress the conﬁguration
of malignant and benign tumors. Honey helps to reduce
the promotion and tumorigenesis and progression of cancer
by reducing the expression of MAPK and NF-κB in cancer-
ous cells. MAPK cascades are the main signaling pathways
in the regulation of cell proliferation, survival, and diﬀer-
entiation. NF-κB is a transcription factor which is vital
in the regulation of immune responses, inﬂammation, and
oncogenesis. NF-κB translocation to the nucleus and reduced
IκBα degradation help to regulate the expression of genes
involved in apoptosis and proliferation that are responsible
for the development of cancer. Flavonoids found in honey
have been shown to induce apoptosis and prevent the release
of IL-1β, IL-6, TNF-α, iNOS, and COX-2 [84].
Tumors, malignancies, and cancers are usually enhanced
by obesity and insulin-resistant type 2 diabetes mellitus.
PI3K/Akt is an important pathway in insulin signaling. The
PI3K/Akt pathway is also recognized in modulating sub-
strates that are related to cellular growth, survival, and pro-
gression. Elevated levels of MAPK, NF-κB, and insulin
receptor substrate 1 (IRS-1) along with reduced levels of
Akt expression have been actively linked to the development
of insulin resistance. Honey components such as quercetin
revive insulin resistance by increasing the expression of Akt
while reducing the expression of IRS, MAPK, and NF-κB.
Modulation of insulin signaling by honey leads to anticancer
activities [84].
Honey has debridement eﬀects by boosting epithelializa-
tion and stimulates the development of granulation tissue
through its angiogenic eﬀect on the vasculature. Honey selec-
tively stimulates angiogenesis in noncancer tissues through
the production of hydrogen peroxide while inhibiting angio-
genesis in cancer tissues. Honey has antiangiogenic eﬀects
that prevents the wound-healing response, reduces the viabil-
ity of cancer cells, and lowers the incidence of metastasis by
inhibiting the activities of gelatinase and protease. Honey
prevents the development of cancer by blocking the three
main stages of cancer formation known as initiation, prolifer-
ation, and progression [84].
5. Health Benefits of Propolis
5.1. Gastrointestinal Disorder. Infection with parasites usu-
ally occurs upon contact with an infected surface. The symp-
toms of parasitic infection of the GI tract include abdominal
pain, diarrhea, bloating, and nausea. Propolis has been
reported to have several biological eﬃcacies including anti-
cancer, antioxidant, and anti-inﬂammatory activities
(Figure 3). There are a few studies that reported the clinical
use of propolis in the treatment of viral infections. In one
study, the in vitro eﬀect of propolis ethanolic extract on the
growth and adherence of Giardia duodenalis trophozoites
was evaluated [91]. Propolis was shown to inhibit growth
and adherence of the trophozoites. It also promoted the
detachment of these parasitic organisms. Its eﬃcacy against
giardiasis has also been reported in a clinical study whereby
children and adults with giardiasis-given propolis showed a
cure rate between 52% and 60%, whereas those given the con-
ventional drug showed a 40% cure rate. Another experimen-
tal study showed that propolis has antihistaminergic, anti-
inﬂammatory, antiacid, and anti-H. pylori activities that can
be used to treat gastric ulceration [92].
5.2. Gynecological Care. Widespread causes of indicative
vaginitis are bacterial vaginosis (BV) and vulvovaginal
candidiasis (VVC). The depletion of Lactobacillus spp. in
the vagina is a distinguished feature of vaginal infections.
The infection is accompanied by an overgrowth of vaginal
pathogens such as yeast-like fungi and an elevated vaginal
pH. Diabetes patients are more prone to having vaginal
infections caused by Candida albicans. A study conducted
on the application of 5% aqueous propolis solution resulted
in an improvement in vaginal well-being [93]. In addition
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to providing antibiotic and antimycotic actions, propolis
provides early symptomatic relief due to its anesthetic
properties. Thus, propolis may be used for Recurrent Vulvo-
vaginal Candidiasis (RVVC) and can be an alternative option
for patients who are unable to take antibiotics due to a con-
current pharmacological treatment. The eﬀectiveness of
propolis against conventional antifungal nystatin has shown
satisfactory results. Propolis extract solution (PES) also
show low toxicity in human cells and can be an alternative
treatment for chronic vaginitis. In addition, PES has antifun-
gal properties and it can be used as antibioﬁlm material for
RVVC to counteract bioﬁlm growth of C. albicans and resis-
tance in antifungal drug [94].
5.3. Oral Health. The oral cavity has an abundant bacterial
microﬂora and excessive bacterial growth may lead to several
conditions such as oral diseases. Studies have shown that
propolis may restrict bacterial-plaque development and
periodontitis-causing pathogens because of its antibacterial
properties [95]. Propolis solutions exert a selectively lower
cytotoxic action on human gum ﬁbroblasts compared to
chlorhexidine. In addition to that, mouthwash containing
propolis have shown eﬀectiveness in healing surgical wounds.
This encourages the use of propolis in solutions used as
mouthwash [96]. Propolis solution can also be used to disin-
fect toothbrushes [97]. A 3% ethanolic extract of propolis
toothpaste gel showed greater potency against gingivitis
caused by dental plague in a group of patients [98]. Propolis
extracts have also helped cure halitosis, a condition where
an individual experiences unpleasant breath predominantly
due to poor oral hygiene. Propolis toothpaste or mouthwash
is used for their ability to reduce growth of bacterial plaque
and pathogenic microﬂora that causes gingivitis and peri-
odontitis. Thus, propolis also plays a role as a therapeutic
agent [95].
5.4. Oncological Treatment. A study reported that propolis
has potential towards human breast cancer treatment due
to its antitumor activity by inducing apoptosis on human
breast cancer cells. It also exhibits low or no toxicity
towards normal cells due to its selectively toxic properties
against tumor cells and is believed that propolis may
become a prominent agent to treat breast cancer [99].
Another study investigating the eﬀect of ethanolic extract of
Algerian propolis on melanoma tumor growth has shown
that galangin, a common ﬂavonoid in propolis remarkably
induced apoptosis and inhibited melanoma cells in vitro
[100]. Turkish propolis has also been shown to exert a selec-
tive cytotoxic action on human lung cancer cells by inducing
endoplasmic reticulum stress, apoptosis, and caspase activity
and by reducing the mitochondrial membrane potential. This
indicates that propolis is able to minimize the cancer cell
proliferation [101].
5.5. Dermatological Care. Propolis is widely used in der-
matological products such as creams and ointments. Its
use in skin care products is based on its antiallergy, anti-
inﬂammation, antimicrobial properties, and promotive
action on collagen synthesis. A recent study comparing
the eﬀect of propolis and the conventional drug silver
sulfadiazine showed that propolis notably decreased free
radical activity in healing the wound beds which supported
the repair process. A clinical study on acne patients using
ethanolic extract propolis showed its high eﬃcacy in the
treatment of acne vulgaris [102]. Propolis also shows pos-
itive collagen metabolism in the wound during the healing
process by increasing the collagen content of tissues [103].
A study demonstrated the use of propolis as an alternative
therapy for wound healing to promote wound closure,
especially under conditions such as human diabetic foot ulcer
(DFU) [104].
The molecular mechanisms responsible for the wound-
healing activity of propolis is shown in Figure 4. Fibronectin
(FN) is a multifunctional glycoprotein of high molecular
weight, which inﬂuences the structural stability and func-
tional properties of various organs and tissues (Stoﬀels,
2013). The ﬁbronectin matrix and its accumulation are
essential for cell migration, cell proliferation, cell diﬀerentia-
tion, cell adhesion, apoptosis, cellular signaling, angiogenesis,
collagen biosynthesis, re-epithelialization, clot formation,
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Figure 3: The biological activities of propolis.
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and platelet activity. Fibronectins are also important in the
repair mechanisms for conditions such as glycoprotein inten-
siﬁed degradation, which leads to a defective cellular micro-
environment and aﬄiction in the structure of granulation
tissues. This condition may prevent the wound from healing
or inhibit the repair process. The accumulation of ﬁbronectin
in the extracellular space also modulates the secretion of
other repairing components such as collagen type I and type
III, tenascin, laminin, and ﬁbrillin.
Propolis has demonstrated favorable eﬀects in the
wound-healing process such as antifungal and antibacterial
activities due to its components such as ﬂavonoids, phenolic
compounds, terpenes, and enzymes. It also reduces the activ-
ity of free radicals (ROS) in the wound bed favoring the
repair process. Propolis has also demonstrated great eﬀects
on collagen metabolism by increasing the amount of both
type I and type III collagens in tissues. The reduction of
ROS and accumulation of collagen aid in balancing the extra-
cellular matrix and generating granulation tissues. Propolis is
a potential apitherapeutic agent that is able to modify the
metabolism of ﬁbronectin by developing a ﬁbrous network
of extracellular matrix and inhibiting ﬁbronectin disinte-
gration. The active components in propolis such as quer-
cetin and resveratrol inhibited ﬁbronectin biosynthesis
and TGF?-dependent production of ﬁbronectin, respec-
tively, in C2C12 myoblasts. Both the components play
important roles in regulating the expression of ﬁbronec-
tins. Studies have also shown that mobility and migration
of epithelial cells are dependent on reduced ﬁbronectin
content in the extracellular matrix. Reduced amounts of
this glycoprotein in propolis eﬀectively treated wounds
and produced granulation tissues. Therefore, the inﬂuence
of propolis on ﬁbronectin metabolism may alter the mech-
anism of wound healing [103]. Several health beneﬁts of
propolis related to gastrointestinal, gynecological care, oral
health, skin care, and oncological treatments are tabulated
in Table 2.
6. Health Benefits of Royal Jelly
Royal jelly is one of the honey bee products which have
potential towards various human disease treatments.
Figure 5 depicts the biological activities of royal jelly as an
antioxidant, antitumor, antiaging, neurotropic, and anti-
inﬂammatory agent.
6.1. Reproductive Health. A randomized clinical study has
reported that royal jelly is eﬀective in reducing premenstrual
syndrome [105]. A randomized clinical trial study reported
the eﬀectiveness of royal jelly in treatment of urinary prob-
lems and promotion of life quality in postmenopausal
women [106]. Royal jelly has protective eﬀects against
Oxymetholone-induced reproductive toxin (OXM), which
is an active steroid derived from testosterone as a defense
mechanism. Recent studies have reported that royal jelly pro-
tects against the oxidative injuries in the mouse testes and
that it contains spermatogenesis-stimulating compounds,
which inhibit the production of proinﬂammatory cytokines
[107]. Another study on male rabbits has indicated its posi-
tive eﬀects on fertility, semen quality and output, and con-
centration of testosterone, total proteins, and glucose in the
blood. The number of dead and abnormal sperm decreased
with the reduction of biomarkers of oxidative stress [108].
Royal jelly has been traditionally used to treat menopause
symptoms by rebalancing the hormonal concentration in
the blood, decreasing follicle-stimulating hormones (FSH)
and increasing the estrogen concentration in aged mice. A
study showed that the changes in hormone levels resulting
from royal jelly increased the amount of ovulated oocytes
and their quality in aged rats [109].
The molecular mechanisms responsible for the antiaging
activity of royal jelly are shown in Figure 6. The quality of
oocytes decreases with age and the depleted follicle pool has-
tens hormonal dysregulation. This hormonal dysfunction is
responsible for the reduction in ovarian follicle size and
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oocyte quality. Oxidative stress is the main cause of aging.
Increased oxidative stress and continuous ovulation causes
loss of antioxidants such as SOD, catalase, and glutathione
S-transferase (GST). It also minimizes the size of the follicle
pool and oocyte quality. Oxidative stress is controlled by glu-
tathione (GSH), glutathione S-transferase (GST), Glutathi-
one S-Transferase Theta 1 (GSTT1), Bax, and Bcl-2. GSH,
GST, and GSTT1 are direct ROS scavengers, which play a
vital role in removing oxidative stress from the cell. Higher
expression of Bax and lower expression of Bcl-2 also promote
aging and reduces oocyte quality.
FSH and luteinizing hormone (LH) are the hormones
involved in the aging process. The amount of FSH and LH
is controlled by estrogen (E2) and inhibin from the ovarian
cells. Reduction of the follicle pool size results in an inade-
quate release of estrogen and inhibin, which results in a rise
in FSH levels. This process then aids in the reduction of the
follicle pool size and aﬀects oocyte quality. This process
promotes aging in the ovaries. In young ovarian cells, higher
amount of estrogen (E2) and inhibins are needed to decrease
the level of FSH and LH. This adaptation can be overcome by
antiaging therapies such as supplemental consumption of
royal jelly. The major active component present in royal jelly
is 10-hydroxyl-2-decenoic acid. This compound enhances
the synthesis of ovulation hormones, maintaining a lower
expression of FSH and LH in young ovarian cells. It is also
eﬃcient in preventing the depletion of follicle pool and in
enhancing hormonal regulation. Thus, royal jelly helps in
preventing the aging process and is an inﬂuential antiaging
product [109].
6.2. Neurodegenerative and Aging Diseases. Poor mental state
and performance such as in the case of Alzheimer’s disease
(AD) are mostly experienced by elderly individuals due to
aging. Royal jelly stimulates physical and mental functions
for the elderly and increases their appetite and weight. A
Table 2: Selected propolis activities according to the health beneﬁts.
Health beneﬁts Propolis activity Type of studies Authors
GI disorder
Antiparasitic Humans Freitas et al. 2006 [91]
Antiulceration Animals Paulino et al. 2015 [92]
Gynecological care
Antifungal Human Imhof et al. 2005 [93]
Antifungal and antibioﬁlm Human Capoci et al. 2015 [94]
Oral health
Antibacterial Laboratory Pereira et al. 2011 [95]
Daily mouthwash Human Jain et al. 2014 [96]
Toothpaste disinfection Laboratory Bertolini et al. 2012 [97]
Toothpaste against gingivitis Human Skaba et al. 2013 [98]
Oral therapeutic agent Human Pereira et al. 2011 [95]
Oncology treatment
Anti-breast cancer Human Xuan et al. 2014 [99]
Antimelanoma cancer Animals Benguedouar et al. 2015 [100]
Anti-lung cancer Human Demir et al. 2016 [101]
Dermatology care
Acne vulgaris Human Ali et al. 2015 [102]
Collagen metabolism Animals Olczyk et al. 2014 [103]
Diabetic foot ulcer Human Henshaw et al. 2014 [104]
Biological
activity of
royal jelly
Antioxidant
Antitumor
Antiaging
Neurotropic
Anti-inflammatory
Figure 5: Diﬀerent types of biological activities of royal Jelly.
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study showed that royal jelly exerted neuroprotective eﬀects
in AD [110]. The behavioral and neurochemical eﬀect of
royal jelly was chemically examined in aged rats. The study
conﬁrmed a better cognitive performance and increased the
life span in the older animals that had been given royal jelly.
Another study reported that royal jelly contains longevity-
promoting factors and extends the lifespan in the nematode
Caenorhabditis elegans [111]. Another study have also
reported the improved mental health in human upon inges-
tion of royal jelly for six months [112]. A few studies on the
health beneﬁts of royal jelly are given in Table 3.
6.3. Wound Healing. Royal jelly enhances wound-healing
activity. In both in vivo and in vitro wound-healing models,
under the eﬀect of royal jelly, human ﬁbroblasts were able
to migrate and increase levels of sphingolipids by decreasing
the secretion and formation of collagen. Thus, royal jelly
shortened the curing period of desquamated skin lesions
[113]. Another study on the use of royal jelly have also exhib-
ited protective action on human skin against ultraviolet B-
induced photoaging by promoting collagen production
[114]. Royal jelly dressing is also an eﬀective way of treating
diabetic foot ulcers besides standard treatments. This is due
to its vasodilation eﬀects around the aﬀected wound, which
can help to dilate the blood vessels to enhance blood ﬂow.
It also helps to prevents infections due to its antimicrobial
activities [115].
7. Conclusion and Future Prospects
The present review focused on the potential health beneﬁts of
bee products such as honey, propolis, and royal jelly. These
products are highly rich in active components such as ﬂavo-
noids, phenolic acid, phenolic compounds, terpenes, and
enzymes, which have biological functions in preventing some
diseases and promoting good health. Honey, propolis, and
Oxidative
stress
Hormonal 
dysregulation
Oocyte
quality
AgingFollicle
pool
Aged 
ovary
FSH/LH
Estrogen/inhibin
Young
ovary
FSH/LH
Estrogen/inhibin10-hydroxyl-2 decenoic-
acid
Prevent to consume follicle pool
Enhance hormonal regulation
Prevent aging
Figure 6: Molecular mechanism responsible for the antiaging activity of royal jelly.
Table 3: Reports on health beneﬁts of royal jelly.
Health beneﬁts Propolis activity Type of studies Authors
Reproductive care
Antioxidant Animals El-Hanoun 2012 [108]
Hormone balance Animals Imai et al. 2012 [109]
Antioxidative agent Animals Najaﬁ et al. 2014 [107]
Reduce premenstrual syndrome Humans Taavoni et al. 2014 [105]
Postmenopausal treatment Humans Seyyedi et al. 2016 [106]
Neurodegenerative and aging disease
Longevity promoting Animals Honda et al. 2011 [111]
Alzheimer’s disease Animals Zamani et al. 2012 [110]
Mental health Human Morita et al. 2012 [112]
Wound healing
Fibroblast migration Animals Kim et al. 2010 [113]
Collagen production Human Park et al. 2011 [114]
Vasodilatation Human Siavash et al. 2015 [115]
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royal jelly have distinct eﬃcacies with signiﬁcant nutritional
properties and functional values. Thus, these bee products
can be developed into potent apitherapeutic agents. How-
ever, some precautions need to be taken in case of allergens
associated with bee products and in ﬁnding the right intake
dosage. Hence, it is necessary to conduct further studies to
determine the critical mechanisms related to the pharmaco-
logical activities of these bee products and the appropriate
amounts that can be taken in order to obtain promising
health beneﬁts.
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